2024 Naperville Essential Evidence Update Conference Schedule
Friday, April 12, 2024
7:30 am | Registration & continental breakfast
8:00 - 8:15 am | Welcome & Course Introduction
8:15 – 9:00 am | Dementia (0.75 credit)
At the end of this session, participants will be able to discuss recent research on:
• Older drugs (i.e., cholinesterase inhibitors) for treating patients with dementia
• Newer drugs (i.e., monoclonal antibodies) for treating patients with dementia
• Approaches to managing troubling behaviors
9:00 - 9:45 am | Pediatric Potpourri (0.75 credit)
At the end of this session, participants will be able to:
• Describe updates in the care of newborns
• Discuss changes to guidelines relevant to the care of children and adolescents
• Explain new pediatrics research relevant to primary care
9:45 -10:00 am | BREAK
10:00 - 10:45 am | Care of the patient with cancer (0.75 credit)
At the end of this session, participants will be able to discuss recent research on:
• Approaches to managing symptoms in patients with cancer
• Communication issues
• Continuity of care and care collaboration
10:45 - 11:30 am | New Drugs (0.75 credit)
At the end of this session, participants will be able to:
• Review the efficacy and safety for several medications FDA-approved within the last 3 years
• Compare new FDA-approved medications to current medications being used in clinical practice, if evidence is available
• Analyze the cost-benefit for several new FDA-approved medications
• Describe the role for each medication within current clinical practice
11:30 am - 12:30 pm | LUNCH
12:30 – 1:15 pm | Women’s Health Update (0.75 credit)
At the end of this session, participants will be able to:
• Discuss updates to pregnancy and perinatal care
• Explain new evidence in contraception and sexually transmitted infection care
• Describe new research relevant to menopause
• Identify practice-relevant information about gynecologic symptoms and conditions
1:15 – 2:00 pm | Musculoskeletal update (0.75 credit)
At the end of this session, participants will be able to discuss recent research on:
• Managing common acute injuries
• Managing patients with osteoarthritis
• Using orthobiologics
2:00 – 2:45 pm | Type 2 diabetes (0.75 credit)
At the end of this session, participants will be able to:
• Summarize changes to the recent ADA guidelines for T2D pharmacologic treatment.
• Discuss the expanding recommendations for SGLT2 inhibitors and GLP-1 receptor agonists.
• Discuss recent research on the effects of continuous glucose monitoring
2:45 – 3:00 pm | BREAK
3:00 – 3:45 pm | Evaluating the patient with chest pain (0.75 credit)
At the end of this session, participants will be able to:
• Describe how to manage a patient with acute chest pain in the outpatient setting, based on ACC/AHA guidelines
• Use the HEAR score (and HET and HEART scores) in evaluating the likelihood that a patient with chest pain has an acute coronary syndrome
• Describe the role of CT angiography in the evaluation of the patient with acute chest pain
3:45 – 4:15 pm | Screening and Prevention (0.75 credit)
At the end of this session, participants will be able to:
• Describe the pros and cons of screening for colorectal cancer starting at age 45 years.
• Understand the best approach to screening for cervical cancer.
• Justify not screening for atrial fibrillation, COPD, diabetes, sleep apnea, and eating disorder
4:15 – 5:00 pm | Editor’s Choice (0.75 credit)
At the end of this session, participants will be able to:
• Discuss recent research critical to family physicians for updating their diagnostic and treatment approaches
Accreditation
The Illinois Academy of Family Physicians (IAFP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
AMA Category 1 credit™ - The Illinois Academy of Family Physicians designates this live activity for a maximum of 7.50 AMA PRA Category 1 credit™
Prescribed - The AAFP has reviewed 2024 Essential Evidence Updates Conference and deemed it acceptable for up to 7.50 Live AAFP Prescribed credit(s). Term of Approval is from 04/12/2024 to 04/12/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
